Article
Abnormal lymphatic S1P signaling aggravates lymphatic dysfunction and tissue inflammation
2023-06-12
Abstract excerpt
<h4>BACKGROUND</h4> Lymphedema is a global health problem with no effective drug treatment. Enhanced T cell immunity and abnormal lymphatic endothelial cell (LEC) signaling are promising therapeutic targets for this condition. Sphingosine-1-phosphate (S1P) mediates a key signaling pathway required for normal LEC function, and altered S1P signaling in LECs could lead to lymphatic disease and pathogenic T cell activ...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7fb8f1f3-9b14-5f0a-87c6-b4d1efe37222
- DOI
- 10.1101/2023.06.08.23291175
